REFERENCES
- Higgs DR, Weatherall DJ. The α thalassaemias. Cell Mol Life Sci. 2009;66(7):1154–1162.
- Weatherall DJ, Clegg JB. Inherited haemoglobin disorders: an increasing global health problem. Bull World Health Organ. 2001;79(8):704–712.
- Neishabury M, Abbasi-Moheb L, Poorfathollah A, α-Thalassemia deletion analysis in Iran. Arch Irn Med. 2002;4(4):160–164.
- Higgs DR. The molecular basis of α-thalassemia. In: Steinberg MH, Forget BG, Higgs DR, Weatherall DJ, Eds. Disorders of Hemoglobin: Genetics, Pathophysiology and Clinical Management, 2nd ed. Cambridge: Cambridge University Press. 2009:241–265.
- Galanello R, Cao A. α-T-thalassemia. Genet Med. 2011;13(2):83–88.
- Zandian K, Nateghi J, Keikhahi B, α-Thalassemia mutations in Khuzestan Province, southwest Iran. Hemoglobin. 2008;32(6):546–552.
- Hadavi V, Taromchi A, Malekpour M, Elucidating the spectrum of α-thalassemia mutations in Iran. Haematologica. 2007;92(7):992–993.
- Hadavi V, Jafroodi M, Hafezi-Nejad N, α-Thalassemia mutations in Gilan Province, North Iran. Hemoglobin. 2009;33(3-4):235–241.
- Harteveld CL, Yavarian M, Zorai A, Quakkelaar ED, Van Delft P, Giordano PC. Molecular spectrum of α-thalassemia in Iranian population of Hormozgan: three novel point mutation defects. Am J Hematol. 2003;74(2):99–103.
- Zareifar S, Jabberi A, Cohan N, Haghpanah S. Efficacy of combined desferrioxamine and deferiprone versus single desferrioxamine therapy in patients with major thalassemia. Arch Iranian Med. 2009;12(5):488–491.
- Samavat A, Modell B. Iranian national thalassemia screening program. Br Med J. 2004;329(7475):1134–1137.
- Karimi M, Johari S, Cohan N. Attitude toward prenatal diagnosis for β-thalassemia major and medical abortion in southern Iran. Hemoglobin. 2010; 34(1):49–54.
- El-Kalla S, Baysal E. Thalassemia in the United Arab Emirates. Acta Haematol. 1998;100(1):49–53.
- Saleh-Gohari N, Khosravi-Mashizi A. Spectrum of α-globin gene mutations in the Kerman Province of Iran. Hemoglobin. 2010;34(5):451–460.